Skip to main content
SpringerLink
Log in

Allelic losses from chromosome 17 in human osteosarcomas

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Genetic alterations of chromosome 17 have been reported to occur frequently both in human sporadic and familial malignancies. The present study was undertaken to explore the possible involvement of chromosome 17 genes including TP53 and the breast cancer susceptibility BRCA1 tumor suppressor genes in the development of sporadic osteogenic sarcoma. Fifteen patients were screened by polymerase chain reaction (PCR) for loss of heterozygosity (LOH) using four highly polymorphic markers. Loss of heterozygosity at the TP53 locus was detected in 40% (6/15) of informative cases while it was 14% (2/14) at the locus of thyroid hormone receptor alpha (THRA1), 21% (3/14) at the D17S855 locus intragenic to BRCA1 and 27% (4/15) at the D17S579 locus. In 53% of the cases studied at least one locus on chromosome 17 was affected by LOH. In our panel, the overall LOH frequency on 17p and 17q was observed to be 40% (6/15) and 27% (4/15), respectively. Comparison of LOH frequencies with clinical and prognostic features revealed significant correlation only with tumor recurrence. Our results confirm that the role of the TP53 tumor suppressor gene is important in the pathogenesis of sporadic osteosarcoma and suggest that 17ql2-21 region abnormalities may be involved in the development and/or progression of this tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andreassen A, Oyjord T, Hovig E et al: p53 abnormalities in different subtypes of human sarcomas. Cancer Res 53:468–471, 1993.

    PubMed  CAS  Google Scholar 

  2. Beckmann MW, Picard F, An HX et al: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73:1220–1226, 1996.

    PubMed  CAS  Google Scholar 

  3. Borg A, Zhang Q-X, Johansson O et al: High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal carcinomas. J Natl Cancer Inst 86:92–94, 1994.

    Article  Google Scholar 

  4. Böhler FK and Rhomberg W: Osteogenesis Imperfecta und Mammakarzinom. Strahlenther Onkol 170:665–667, 1994.

    PubMed  Google Scholar 

  5. Cornells RS, Neuhausen SL, Johansson O et al: High allele loss rates at 17q 12–21 in breast and ovarian tumors from BRCA1 linked families. Genes Chrom and Cancer 13:203–210, 1995.

    Article  Google Scholar 

  6. Cropp CS, Champene M-H, Lidereau R and Callahan R: Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53:5617–5619, 1993.

    PubMed  CAS  Google Scholar 

  7. Cropp CS, Nevanlina HA, Pyrhönen S et al: Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res 54:2548–2551, 1994.

    PubMed  CAS  Google Scholar 

  8. Devilee P and Cornelisse CJ: Chromosome aneuploidy and loss of heterozygosity. Biochim Biophys Acta 1198:113–130, 1994.

    PubMed  Google Scholar 

  9. Ford D, Easton DE Bishop DT et al: Risk of cancer in BRCA1 carriers. Lancet 343:692–695, 1994.

    Article  PubMed  CAS  Google Scholar 

  10. Frebourg T, Barbier N and Yan Z: Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56:608–615, 1995.

    PubMed  CAS  Google Scholar 

  11. Gao X, Zacharek A, Salkowsky A et al: Loss of heterozygosity of BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55:1002–1005, 1995.

    PubMed  CAS  Google Scholar 

  12. Godwin AK, Vanderveer L, Schultz DC et al: A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Am J Hum Genet 55:666–677, 1994.

    PubMed  CAS  Google Scholar 

  13. Grundmann E, Roessner A, Ueda Y et al: New aspects of cell biology of osteosarcoma. Anticancer Res 15:1023–1033, 1995.

    PubMed  CAS  Google Scholar 

  14. Kirschweger R, Zellinger R, Schneeberger C et al: Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer 56:193–199, 1994.

    Article  Google Scholar 

  15. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914–10921, 1993.

    Article  PubMed  CAS  Google Scholar 

  16. van der Looij M, Eig H, Bak M et al: Allele loss of tumour suppressor genes on chromosome 17 in human testicular germ cell tumours. Int J Oncol 9:1087–1090, 1996.

    Google Scholar 

  17. Meyers P, Heler G, Healey J et al: Chemotherapy for non- metastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 10:5–15, 1992.

    PubMed  CAS  Google Scholar 

  18. Miller CW, Aslo A, Tsay C et al: Frequency and structure of p53 rearrangements in human osteosarcomas. Cancer Res 50:7950–7954, 1990.

    PubMed  CAS  Google Scholar 

  19. Miller C and Koeffler P: p53 mutations in human cancer. Leukemia 7:518–521, 1993.

    Google Scholar 

  20. Mori T, Aoki T, Matsubara T et al: Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res 54:1638–1640, 1994.

    PubMed  CAS  Google Scholar 

  21. Mousses S, McAuley L, Bell RS et al: Molecular and immunohis-tochemical identification ot p53 alterations in bone and soft tissue sarcomas. Modern Path 1:1–6, 1996.

    Google Scholar 

  22. Papp J, Csókay B, Bősze P et al: Allele loss from large regions of chromosome 17 is common only in certain histo-logical subtypes of ovarian carcinomas. Br J Cancer 74:1592–1597, 1996.

    PubMed  CAS  Google Scholar 

  23. Smith R: Osteogenesis imperfecta: from phenotype to genotype and back again. Int J Exp Path 75:233–241, 1994.

    CAS  Google Scholar 

  24. Tangir J, Muto MG, Berkowitz RS et al: A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene 12:735–740, 1996.

    PubMed  CAS  Google Scholar 

  25. Tarkannen M, Karhu R, Kallioniemi A et al: Gains and losses of DNA sequences in osteosarcoma by comparative genomic hybridization. Cancer Res 55:1334–1338, 1995.

    Google Scholar 

  26. Tavassoli M, Ruhrberg C, Beaumont V et al: Whole chromosome 17 loss in ovarian cancer. Genes Chrom and Cancer 8:195–198, 1993.

    Article  CAS  Google Scholar 

  27. Toguchida J, Ishizaki K, Sasaki MS et al: Assignment of common allele loss on osteosarcoma to the subregion 17pl3. Cancer Res 49:6247–6251, 1989.

    PubMed  CAS  Google Scholar 

  28. Toguchida J, Ishizaki K, Sasaki MS et al: Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48:3939–3943, 1988.

    PubMed  CAS  Google Scholar 

  29. Yamaghuci T, Toguchida J, Yamamuro T et al: Allelotype analysis in osteosarcomas frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52:2419–2423, 1992.

    Google Scholar 

  30. Wilson CA, Payton MN, Pekar SK et al: Antibody specifity, functional motifs and secreted tumor suppressors. Nature Genet 13:264–270, 1996.

    Article  PubMed  CAS  Google Scholar 

  31. Winkler K and Bielach S: Chemotherapy of osteosarcoma. Sem Orthop 3:48–58, 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Biology, National Institute of Oncology, Rath György u. 7–9, H-1525, Budapest, Hungary

    Marianna SztÁn, Marco Van Der Looij & Edith OlÁh

  2. Internal Medicine, National Institute of Oncology, Budapest, Hungary

    Zsuzsa PÁpai

  3. Institute of Orthopedics, Semmelweis Medical University, Budapest, Hungary

    Miklós SzendrŐi

Authors
  1. Marianna SztÁn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zsuzsa PÁpai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miklós SzendrŐi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Van Der Looij
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Edith OlÁh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edith OlÁh.

Additional information

This work has been supported by OTKA T-19037 and ETT Grants given to E.O.

Rights and permissions

Reprints and permissions

About this article

Cite this article

SztÁn, M., PÁpai, Z., SzendrŐi, M. et al. Allelic losses from chromosome 17 in human osteosarcomas. Pathol. Oncol. Res. 3, 115–120 (1997). https://doi.org/10.1007/BF02907805

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02907805

Keywords

Search

Navigation